0
0.0
Mar 8, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the biogen stock, shares are down over 10% this year. what is your trade on biogen? >> a sell.enge was that they have their sales which did not meet expectations and they underperformed. they argued they had a patient access issues and other logistical issues. the postpartum depression drug has not performed as expected. they have announced efforts to cut costs by the end of the year. that will save about $400 million, and help earnings, not the story investors can get behind. >> let's move on, that is a cell. docusing, shares higher after they defeated fourth quarter estimates, shares up 30% since the start of december. can they keep on rolling? >> we are neutral on this one. we could get excited about it. the challenge is that docusign was a pandemic darling, when assigning things remotely was a challenge, they had a nice and beautiful, slick and simple product. adobe quickly caught on and is a significant competitor and a much more mature ecosystem that they have built. docusign has done better than i would've expected because they have continued and kept their base of custo
the biogen stock, shares are down over 10% this year. what is your trade on biogen? >> a sell.enge was that they have their sales which did not meet expectations and they underperformed. they argued they had a patient access issues and other logistical issues. the postpartum depression drug has not performed as expected. they have announced efforts to cut costs by the end of the year. that will save about $400 million, and help earnings, not the story investors can get behind. >>...
0
0.0
tv
eye 0
favorite 0
quote 0
they were repeated again by president joe biogen, the old of the entire united states government to comb bucks every effort to criminalize eligibility status. i don't want to on the line that was come back home, but he's an act will come, but is a statement that relieves all the assets of that particular power to enter into was indeed america. you are peter, you are in a culture will, but i'm excited that the honorable mom will come during the as the has defied that intimidation. i've spoken about this. so for a new t of georgia, she's repeat of the fact that the cost is sort of georgia. this is 2018 has made almost sexuality, bach fried some 6 x are, are criminal from average is criminal. i think that more and more countries are going to come up with laws against it. less full. so now do be sure to check out the uh t dot com for all of the latest breaking news and updates. and we'll see you right back here to something. yeah, the, the, the the, the, [000:00:00;00] the, the russian states never saw one of the most sense community best. most all sun set up the same assistance must be the
they were repeated again by president joe biogen, the old of the entire united states government to comb bucks every effort to criminalize eligibility status. i don't want to on the line that was come back home, but he's an act will come, but is a statement that relieves all the assets of that particular power to enter into was indeed america. you are peter, you are in a culture will, but i'm excited that the honorable mom will come during the as the has defied that intimidation. i've spoken...
0
0.0
Mar 1, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
it will be approved by ludlow and biogen. without your screening, it's possible everyone in the world would demand these treatments. we can do that. you are talking about four mri screenings that may -- who should be eligible for these. >> the mri scan actually is done after a patient has been determined appropriate to on a trial of the new drugs. the current one that is most talked about is a look and be, but once you do the pet ct scan or pet mri scan, to determine whether or not they are a candidate for the new drugs, then for follow-up treatment, because of the side effects that these drugs can cause that has changes occurring in the brain that we use the mri for detection to avoid complications where the cure might be worse than the disease . so, the mri volume as a result of more and more of these patients being diagnosed as an eligible candidate for the drug will have to be followed up by routine mri scanning on a pretty regular basis. >> no one ants to have to say this, sir, i think you are one of the best positions a
it will be approved by ludlow and biogen. without your screening, it's possible everyone in the world would demand these treatments. we can do that. you are talking about four mri screenings that may -- who should be eligible for these. >> the mri scan actually is done after a patient has been determined appropriate to on a trial of the new drugs. the current one that is most talked about is a look and be, but once you do the pet ct scan or pet mri scan, to determine whether or not they...
0
0.0
Mar 6, 2024
03/24
by
CNBC
tv
eye 0
favorite 0
quote 0
but you have biogen out there with an approved drug.ng on line later this year. this is another massive category. i think it's been kind of plagued by various fits and starts along the way, you know, in terms of market development and data. now that we're going to have two major players creating this market over the next few years, this is one that i would kind of look at and say we're not really paying for it. we know there are an abundance of patients out there and we'll have drugs that treat this, albeit probably not perfect yet. but we're kind of in the first inning of what could be an interesting alzheimer's disease buildout. it's just not as interesting for investors right now versus the glps. >> jerald holtz, great to get your thoughts. come to see us again soon, sir. >>> speaking of health care, don't miss our interview with cigna ceo david cordani tomorrow 1:30 p.m. eastern time. so from the drugs in biotech to the insurance side of things, it's all interconnected. >>> coming up, financials are sinking on reports that new york
but you have biogen out there with an approved drug.ng on line later this year. this is another massive category. i think it's been kind of plagued by various fits and starts along the way, you know, in terms of market development and data. now that we're going to have two major players creating this market over the next few years, this is one that i would kind of look at and say we're not really paying for it. we know there are an abundance of patients out there and we'll have drugs that treat...
0
0.0
tv
eye 0
favorite 0
quote 0
biogen, clear way, amd, of course, micron technologieses up again?o the moon. >>> coming up, it's friday, so don't forget to send in your feedback. you can e-mail your questions, comments and critiques to varney viewers@fox.com. please, please, keep them short is and pithy, please. >>> the attorney general of new york, letitia james, didn't get a warm welcome from new york's fire department. no, she didn't. roll tape. [background sounds] >> oh, come on, we're in a house of god. [background sounds] >> first, simmer down. i want to thank commissioner kavanaugh and and chief hodgens for that recognition. aught stuart did you hear that? trump, trump, trump. how about that, in new york city. they're chanting for trump. amaze being. >>> and it took biden roughly 40 minutes to address the border crisis last night. he's ready to fix the problem. what is he actually going if to do? sheriff mark lamb is here, and he's to not happy with the president on the border. -- he's not happy with the president on the border. we'll be back. ♪ ♪ (♪) is bad debt holding yo
biogen, clear way, amd, of course, micron technologieses up again?o the moon. >>> coming up, it's friday, so don't forget to send in your feedback. you can e-mail your questions, comments and critiques to varney viewers@fox.com. please, please, keep them short is and pithy, please. >>> the attorney general of new york, letitia james, didn't get a warm welcome from new york's fire department. no, she didn't. roll tape. [background sounds] >> oh, come on, we're in a house...